We’re beginning to wonder what the end game is for this debate over the “high” cost of insulin. Are the advocates for lower out of pocket costs doing this so that insulin using patients save money or achieve better outcomes. Listen we have no problem if this is all about money nor do have a problem if it’s about better outcomes. However, it can’t be both. Either this is about helping the patient save money or helping the patient achieve better outcomes.
We mention this as we have read another study that attempts to correlate . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.